CD4 and breast cancer: Tfh is a CD4 T helper subset (T follicular helper) was recently found to correlate with improved survival when increased in tumors and, along with B cells, can mediate the response to checkpoint inhibitors in mouse models of augmented mutation burden in breast cancer [41].